To date, studies on GPR158 have focused on Alzheimer’s disease (AD) [16,17], depression [4,14,18,19], tumors [13,20,21,22,23,24,25,26], and ocular hypertension [12,27,28]. This evidence concerns the gene GPR158 and early-onset autosomal dominant Alzheimer disease.